High prolactin levels as a worsening factor for migraine

被引:40
作者
Cavestro C. [1 ]
Rosatello A. [2 ]
Marino M.P. [3 ]
Micca G. [4 ]
Asteggiano G. [5 ]
机构
[1] Department of Neurology, S. Lazzaro Hospital A.S.L., Alba, CN
[2] Serv. Endocrinology, S. Lazzaro Hospital, Alba, CN
[3] Department of Internal Medicine, S. Lazzaro Hospital, Alba, CN
[4] Clinical Laboratory, S. Lazzaro Hospital, Alba, CN
[5] Department of Neurology, S. Lazzaro Hospital, Alba, CN
关键词
Chronic headache; Chronic migraine; Hyperprolactinaemia; Prolactin;
D O I
10.1007/s10194-006-0272-8
中图分类号
学科分类号
摘要
Many factors should be considered when an episodic migraine worsens and becomes chronic. Prolactin (PRL) was linked to the origin of pain in patients with microprolactinomas who developed different types of headaches. Our team carried out studies on 27 patients with a background of episodic headaches that became chronic. The patients were evaluated by means of a general examination, a neurological examination and a hormonal profile. Of the 27 patients, 7 of them had an increased level of prolactinaemia. All the patients were women, ranging from 17 to 57 years of age. Four of them had a pure form of migraine without aura, whereas 3 patients had both migraines without aura and tension-type headaches. They suffered from headache for a period ranging from 3 to 32 years and their headache became chronic 4-12 months prior to the visit. Their headache did not change in type, but only in severity and frequency. Two patients had no symptoms referable to high PRL levels; 4 patients had irregular menses or amenorrhoea. One of these patients also suffered galactorrhoea and two of these patients had a microprolactinoma at MRI; one patient was using estroprogestinic drugs, so her menstrual alteration could not be considered. The patients were followed-up for a period of 6-16 months. Six patients responded favourably after being treated with cabergoline, although some had already tried other drugs, which, however, had no effect on their headache. One patient improved after ceasing to take estroprogestinic, in spite of increased levels of PRL. Therefore, on this basis, PRL levels should always be considered when headache worsens. It is an adjunctive worsening factor, which can be easily eliminated. © Springer-Verlag Italia 2006.
引用
收藏
页码:83 / 89
页数:6
相关论文
共 32 条
[1]  
D'Andrea G., Perini F., Terrazzino S., Nordera G.P., Contributions of biochemistry to the pathogenesis of primary headaches, Neurol Sci, 25, SUPPL. 3, (2004)
[2]  
Welch K.M.A., Research developments in the physiopathology of primary headaches, Neurol Sci, 25, SUPPL. 3, (2004)
[3]  
Silberstein S.D., Meriam G.R., Sex hormones and headache, J Pain Symptom Manage, 8, pp. 98-114, (1993)
[4]  
Drummond P.D., Lance J.W., Neurovascular disturbances in headache patients, Clin Exp Neurol, 20, pp. 93-99, (1984)
[5]  
Rasmussen B.K., Olesen J., Migraine with aura and migraine without aura: An epidemiological study, Cephalalgia, 12, pp. 221-228, (1992)
[6]  
Nappi G., Martignoni E., Bono G., Savoldi F., Murialdo G., Polleri A., THDA system function in migraine, Progress in Migraine Research 1, pp. 110-123, (1981)
[7]  
Polleri A., Nappi G., Murialdo G., Martignoni E., Sances G., Zauli C., Savoldi F., THDA neuron impairment and oestrogen receptor modulation in headache, Progress in Migraine Research 2, pp. 205-215, (1984)
[8]  
Murialdo G., Martignoni E., Maria A.D., Bonura M.L., Sances G., Bono G., Polleri A., Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine, Headache, 26, pp. 9-12, (1986)
[9]  
Bussone G., Frediani F., Lamperti E., LaMantia L., Vescovi A., Peccarisi C., Boiardi A., Piribedil test in migraine: Neuroendocrinological aspects, Headache, 26, pp. 482-485, (1986)
[10]  
Nattero G., Corno M., Savi L., Isaia G.C., Priolo C., Mussetta M., Prolactin and migraine: Effect of L-dopa on plasma prolactin levels in migraineurs and normal, Headache, 26, pp. 9-12, (1986)